Evidence map›Paper›PMID 35335363›Full record

ArticleMolecules (Basel, Switzerland)2022

Dry Dosage Forms of Add-Value Bioactive Phenolic Compounds by Supercritical CO

Clarinda Costa, Hugo Anselmo, Rita Ferro, Ana Sofia Matos, Teresa Casimiro, Ana Aguiar-Ricardo

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Clarinda CostaLAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829-516 Costa da Caparica, Portugal.
Hugo AnselmoLAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829-516 Costa da Caparica, Portugal.
Rita FerroLAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829-516 Costa da Caparica, Portugal.
Ana Sofia MatosDepartamento de Engenharia Mecânica e Industrial, UNIDEMI, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829-516 Costa da Caparica, Portugal.ORCID 0000-0002-4659-0275
Teresa CasimiroLAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829-516 Costa da Caparica, Portugal.
Ana Aguiar-RicardoLAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829-516 Costa da Caparica, Portugal.ORCID 0000-0002-2193-1440
Rede de Química e Tecnologia · PTUniversidade Nova de Lisboa · PT

Funding

Fundação para a Ciência e Tecnologia PTDC/BII-BIO/30884/2017
6 · The paper itself

Abstract

Every year, grapevine pruning produces huge amounts of residue, 90% of which are from vine shoots. These are a rich source of natural antioxidants, mostly phenolic compounds, which, when properly extracted, can give rise to added-value products. However, their lack of solubility in aqueous media and high susceptibility to thermal and oxidative degradation highly limit their bioavailability. Encapsulation in suitable carriers may have a positive impact on their bioavailability and bioactivity. Previous data on vine-shoot extraction have identified gallic acid (GA) and resveratrol (RSV) as the main phenolic compounds. In this work, model dry powder formulations (DPFs) of GA and RSV using hydroxypropyl cellulose (HPC) as carriers were developed using Supercritical CO

Indexed as

Carbon DioxideSpray DryingDesiccationPhenolsPlant ExtractsCarbon DioxidePhenolsPlant Extractsdry powderencapsulationgallic acidhydroxypropyl cellulosequality by designresveratrol

Identifiers

PMID35335363
PMCPMC8950927
OpenAlexW4220855842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.